Does RIBAVIRIN Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with RIBAVIRIN (Ribavirin). This represents 0.0% of all adverse event reports for RIBAVIRIN.
6
Reports of Malignant neoplasm progression with RIBAVIRIN
0.0%
of all RIBAVIRIN reports
2
Deaths
3
Hospitalizations
How Dangerous Is Malignant neoplasm progression From RIBAVIRIN?
Of the 6 reports, 2 (33.3%) resulted in death, 3 (50.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBAVIRIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does RIBAVIRIN Cause?
Fatigue (5,565)
Anaemia (5,130)
Nausea (4,434)
Headache (3,497)
Rash (2,686)
Insomnia (2,653)
Pruritus (2,490)
Pyrexia (2,487)
Drug ineffective (2,364)
Vomiting (2,280)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which RIBAVIRIN Alternatives Have Lower Malignant neoplasm progression Risk?
RIBAVIRIN vs RIBOCICLIB
RIBAVIRIN vs RIBOFLAVIN
RIBAVIRIN vs RIBOFLAVIN 5'-PHOSPHATE
RIBAVIRIN vs RIBOFLAVIN 5^-PHOSPHATE
RIBAVIRIN vs RIFABUTIN